{"id":1639,"date":"2019-04-15T13:13:09","date_gmt":"2019-04-15T11:13:09","guid":{"rendered":"http:\/\/www.nanexa.com\/?p=1639"},"modified":"2019-04-24T13:14:30","modified_gmt":"2019-04-24T11:14:30","slug":"nanexa-har-haft-en-bra-start-pa-aret","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-har-haft-en-bra-start-pa-aret\/","title":{"rendered":"Nanexa har haft en bra start p\u00e5 \u00e5ret"},"content":{"rendered":"<p><strong>Nyhetsbrev <\/strong><\/p>\n<p>Uppsala 2019-04-15<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Nanexa har haft en bra start p\u00e5 \u00e5ret <\/strong><\/p>\n<p>F\u00f6rsta kvartalet av 2019 har varit ett intensivt kvartal f\u00f6r oss p\u00e5 Nanexa. I och med de tre avtalen vi skrev i slutet av f\u00f6reg\u00e5ende \u00e5r har vi varit fullt upptagna med att leverera i de samarbetena. Vi har ytterligare aktiviteter att utf\u00f6ra f\u00f6r att avsluta dessa initiala utv\u00e4rderingar av PharmaShell<sup>\u00ae<\/sup>f\u00f6r respektive bolags aktiva substanser, men diskussioner p\u00e5g\u00e5r redan om m\u00f6jliga forts\u00e4ttningar.<\/p>\n<p>Arbetet med AstraZeneca p\u00e5g\u00e5r ocks\u00e5 enligt plan och d\u00e4r har ytterligare en djurstudie startats i deras regi som ett led i den breddning av samarbetet som kommunicerades under h\u00f6stan 2018.<\/p>\n<p>Parallellt med det ovan n\u00e4mnda har vi arbetat vidare i NEX-18 projektet. Vi har genomf\u00f6rt v\u00e5r f\u00f6rsta djurstudie med PharmaShell<sup>\u00ae<\/sup>-coatad azacitidin och i den genererat v\u00e4rdefull data f\u00f6r att kunna optimera PharmaShell<sup>\u00ae<\/sup>-processen till den m\u00e5lbild f\u00f6r fris\u00e4ttning vi har.<\/p>\n<p>Arbetet f\u00f6r att ta fram regulatorisk och klinisk utvecklingsstrategi f\u00f6r NEX-18 p\u00e5g\u00e5r b\u00e5de f\u00f6r den europeiska och amerikanska marknaden. V\u00e5r m\u00e5ls\u00e4ttning \u00e4r att skapa en s\u00e5 kort och kostnadseffektiv utvecklingsplan som m\u00f6jligt.<\/p>\n<p>P\u00e5 laboratoriet i Uppsala har vi ocks\u00e5 under f\u00f6rsta kvartalet installerat v\u00e5r tredje ALD-reaktor samt ut\u00f6kat v\u00e5r kapacitet med ytterligare analytisk utrustning. Vi har nu ocks\u00e5 f\u00f6rst\u00e4rkt v\u00e5r grupp med ytterligare en medarbetare med masterexamen i materialkemi, som kommer f\u00f6rst\u00e4rka v\u00e5r kacapitet f\u00f6r utvecklingen av PharmaShell<sup>\u00ae<\/sup>.<\/p>\n<p>P\u00e5 den kommersiella sidan har vi hunnit med tv\u00e5 konferenser; dels Drug Delivery Partnerships i Florida i januari och dels BIO-Europe i Wien i mars. Under konferenserna har vi haft flertalet bra m\u00f6ten och diskussioner med intressanta l\u00e4kemedelsf\u00f6retag.<\/p>\n<p>Det kan ocks\u00e5 n\u00e4mnas att Nanexa och PharmaShell<sup>\u00ae<\/sup>nu f\u00f6r f\u00f6rsta g\u00e5ngen belysts i en global marknadsanalys \u00f6ver nya drug delivery-teknologier f\u00f6r biologics &#8211; \u201dNovel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030\u201d (Roots analysis, Business research and consulting).<\/p>\n<p>&nbsp;<\/p>\n<p>Nanexas VD David Westberg kommenterar:<\/p>\n<p><em>Det har varit en riktigt bra start p\u00e5 \u00e5ret och riktigt roligt att vi blir uppm\u00e4rksammade i externa marknadsrapporter. <\/em>Gl\u00e4djande \u00e4r att det g\u00e5tt riktigt bra i de samarbeten vi har och att vi kunnat leverera enligt \u00f6verenskomna planer med samarbetsparnerna.<em>Jag k\u00e4nner stor tillf\u00f6rsikt att resten av \u00e5ret kommer f\u00f6lja i samma positiva riktning.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>F\u00f6r mer information kontakta:<\/p>\n<p>David Westberg \u2013 VD, Nanexa AB (publ)<\/p>\n<p>Telefon: 0709 &#8211; 42 83 03<\/p>\n<p>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\">david.westberg@nanexa.se<\/a><\/p>\n<p>www.nanexa.com<\/p>\n<p>&nbsp;<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<sup>\u00ae<\/sup>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<sup>\u00ae\u00a0<\/sup>har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nyhetsbrev <\/p>\n<p>Uppsala 2019-04-15<\/p>\n<p>&nbsp;<\/p>\n<p>Nanexa har haft en bra start p\u00e5 \u00e5ret <\/p>\n<p>F\u00f6rsta kvartalet av 2019 har varit ett intensivt kvartal f\u00f6r oss p\u00e5 Nanexa.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nanexa-har-haft-en-bra-start-pa-aret\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1639","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa har haft en bra start p\u00e5 \u00e5ret - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa har haft en bra start p\u00e5 \u00e5ret - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nyhetsbrev Uppsala 2019-04-15 &nbsp; Nanexa har haft en bra start p\u00e5 \u00e5ret F\u00f6rsta kvartalet av 2019 har varit ett intensivt kvartal f\u00f6r oss p\u00e5 Nanexa.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-15T11:13:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-04-24T11:14:30+00:00\" \/>\n<meta name=\"author\" content=\"Anders Johansson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Johansson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-haft-en-bra-start-pa-aret\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-haft-en-bra-start-pa-aret\\\/\"},\"author\":{\"name\":\"Anders Johansson\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\"},\"headline\":\"Nanexa har haft en bra start p\u00e5 \u00e5ret\",\"datePublished\":\"2019-04-15T11:13:09+00:00\",\"dateModified\":\"2019-04-24T11:14:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-haft-en-bra-start-pa-aret\\\/\"},\"wordCount\":506,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Nyheter\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-haft-en-bra-start-pa-aret\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-haft-en-bra-start-pa-aret\\\/\",\"name\":\"Nanexa har haft en bra start p\u00e5 \u00e5ret - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2019-04-15T11:13:09+00:00\",\"dateModified\":\"2019-04-24T11:14:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-haft-en-bra-start-pa-aret\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-har-haft-en-bra-start-pa-aret\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-haft-en-bra-start-pa-aret\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa har haft en bra start p\u00e5 \u00e5ret\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\",\"name\":\"Anders Johansson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"caption\":\"Anders Johansson\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa har haft en bra start p\u00e5 \u00e5ret - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa har haft en bra start p\u00e5 \u00e5ret - Nanexa AB","og_description":"Nyhetsbrev Uppsala 2019-04-15 &nbsp; Nanexa har haft en bra start p\u00e5 \u00e5ret F\u00f6rsta kvartalet av 2019 har varit ett intensivt kvartal f\u00f6r oss p\u00e5 Nanexa.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/","og_site_name":"Nanexa AB","article_published_time":"2019-04-15T11:13:09+00:00","article_modified_time":"2019-04-24T11:14:30+00:00","author":"Anders Johansson","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Anders Johansson","Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/"},"author":{"name":"Anders Johansson","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a"},"headline":"Nanexa har haft en bra start p\u00e5 \u00e5ret","datePublished":"2019-04-15T11:13:09+00:00","dateModified":"2019-04-24T11:14:30+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/"},"wordCount":506,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Nyheter"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/","url":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/","name":"Nanexa har haft en bra start p\u00e5 \u00e5ret - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2019-04-15T11:13:09+00:00","dateModified":"2019-04-24T11:14:30+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-har-haft-en-bra-start-pa-aret\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa har haft en bra start p\u00e5 \u00e5ret"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a","name":"Anders Johansson","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","caption":"Anders Johansson"},"url":"https:\/\/nanexa.com\/sv\/author\/anders\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=1639"}],"version-history":[{"count":1,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1639\/revisions"}],"predecessor-version":[{"id":1640,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1639\/revisions\/1640"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=1639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=1639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=1639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}